header
Image from OpenLibrary

Treatment of malignant pleural mesothelioma by gemcitabine and platinum : Experience of the National Cancer Institute Cairo University / Dalia Abdelmoniem Saad Mohammed ; Supervised Rabab Gaafar , Raafat Abdelfattah

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Dalia Abdelmoniem Saad Mohammed , 2014Description: 119 P. ; 25cmOther title:
  • خبرة المعهد القومى للاورام-جامعة القاهرة : {uFECB}{uFEFC}{uFE9D} {uFE8D}{uFEED}{uFEAD}{uFE8D}{uFEE1} {uFE8D}{uFEDF}{uFED0}{uFEB7}{uFE8E}ء {uئإ٨ؤ}{uئإؤئ}{uئإ٩١}{uئإإ٠}{uئإإؤ}{uئإءؤ}{uئإئ١} {uئإ٩١}{uئإ٨إ}{uئإآ٣}{uئإ٩٧}{uئإء٧}{uئإء٩}{uئإ٨ؤ}{uئإإ١} {uئإ٩ئ}{uئإئ٣}{uئإإ٣}{uئإآ٣}{uئإئ٣}{uئإ٩٧}{uئإ٨إ}{uئإ٩١}{uئإئ٣}{uئإإ٥} {uئإإؤ}{uئإ٩١}{uئإئأ}{uئإ٩٧}{uئإئ٤}{uئإإ٨}{uئإإ٢} [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical Summary: Malignant pleural mesothelioma (MPM) is a rare form of cancer that develops from cells of the mesothelium. Pleural mesothelioma accounts for about 75 percent of all diagnoses of asbestos-related cancers. The disease forms in the pleura and is attributed directly to occupational exposure to airborne asbestos fibers. International incidence of malignant mesothelioma is 0.9 case per 100,000 persons annually. US incidence is 2500-3500 cases diagnosed per year. The incidence of MPM in Egypt showed a steady increase from 24 cases in 1998 to 82 cases in 2005 followed by a gradual decline to 68 cases in 2006 and 51 cases in 2007. Malignant mesothelioma is a difficult diagnosis to establish.The current treatment for advanced MPM is platinum based combination chemotherapy (Standard regiment based on phase 3 trials are Vogelzang 2003 used pemetrexed and cisplatin and Van Meerbeeck 2005 used raltitrexed and cisplatin.). The combination of gemcitabine and platinum (NCI) Egypt during the period 1/2010-12/2012.It also evaluated the efficacy of Gemcitabine and Platinum in the treatment as regarding to the response rate : overall survival and progression free survival
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.M.Sc.2014.Da.T (Browse shelf(Opens below)) Not for loan 01010110064797000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.M.Sc.2014.Da.T (Browse shelf(Opens below)) 64797.CD Not for loan 01020110064797000

Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical

Malignant pleural mesothelioma (MPM) is a rare form of cancer that develops from cells of the mesothelium. Pleural mesothelioma accounts for about 75 percent of all diagnoses of asbestos-related cancers. The disease forms in the pleura and is attributed directly to occupational exposure to airborne asbestos fibers. International incidence of malignant mesothelioma is 0.9 case per 100,000 persons annually. US incidence is 2500-3500 cases diagnosed per year. The incidence of MPM in Egypt showed a steady increase from 24 cases in 1998 to 82 cases in 2005 followed by a gradual decline to 68 cases in 2006 and 51 cases in 2007. Malignant mesothelioma is a difficult diagnosis to establish.The current treatment for advanced MPM is platinum based combination chemotherapy (Standard regiment based on phase 3 trials are Vogelzang 2003 used pemetrexed and cisplatin and Van Meerbeeck 2005 used raltitrexed and cisplatin.). The combination of gemcitabine and platinum (NCI) Egypt during the period 1/2010-12/2012.It also evaluated the efficacy of Gemcitabine and Platinum in the treatment as regarding to the response rate : overall survival and progression free survival

Issued also as CD

There are no comments on this title.

to post a comment.